Hospital- and community-acquired MRSA, VRE, CDI and ESBL prevalence rates (per 1000 patient-days) (colonised and infected cases) (January to December 2008)
| January | February | March | April | May | June | July | August | September | October | November | December | |
| MRSA | 5.01 | 3.25 | 1.69 | 1.66 | 1.77 | 1.66 | 1.74 | 1.94 | 3.60 | 0 | 6.69 | 1.67 |
| VRE | 5.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.7 | 0 | 0 |
| CDI | 5.0 | 8.13 | 3.37 | 3.32 | 5.31 | 3.32 | 0 | 1.94 | 5.40 | 5.12 | 1.67 | 8.33 |
| ESBL | 25 | 9.76 | 16.9 | 18.2 | 21.2 | 16.6 | 22.6 | 32.9 | 23.4 | 42.7 | 28.4 | 33.3 |
CDI, Clostridium difficile infections; ESBL, extended spectrum beta-lactamase; MRSA, methicillin-resistant Staphylococcus aureus; VRE, vancomycin-resistant enterococci.